About Q Bio
Q Bio is a company based in Redwood City (United States) founded in 2015 by Michael Snyder, Jeffrey Kaditz, and Garry Choy. Q Bio has raised $67.1 million across 4 funding rounds from investors including Khosla Ventures, Andreessen Horowitz and Founders Fund. The company has 27 employees as of December 31, 2024. Q Bio offers products and services including Gemini Exam and Digital Twin. Q Bio operates in a competitive market with competitors including Briya, Medchart, Seqster, EMIS Health and Emyria, among others.
- Headquarter Redwood City, United States
- Employees 27 as on 31 Dec, 2024
- Founders Michael Snyder, Jeffrey Kaditz, Garry Choy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Q Bio, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$67.1 M (USD)
in 4 rounds
-
Latest Funding Round
$27.1 M (USD), Series B
Mar 26, 2024
-
Investors
Khosla Ventures
& 6 more
-
Employee Count
27
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Q Bio
Q Bio offers a comprehensive portfolio of products and services, including Gemini Exam and Digital Twin.
Streamlined physical exam integrating labs, genetics, and MRI for preventive care.
Uses data to create health models for proactive risk assessment and forecasting.
People of Q Bio
Unlock access to complete
Funding Insights of Q Bio
Q Bio has successfully raised a total of $67.1M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $27.1 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Q Bio
Q Bio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, Andreessen Horowitz and Founders Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Locked | Locked | Locked | |
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Venture capital investments in technology and defense sectors.
|
Locked | Locked | Locked |
Investor details for Q Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Q Bio
Investment portfolio details for Q Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Q Bio
Detailed financials for Q Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Q Bio Comparisons
Peer comparison for Q Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Q Bio
Q Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Briya, Medchart, Seqster, EMIS Health and Emyria, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based tools for medical data collaboration and management are provided.
|
|
| Locked | Locked | Locked |
Cloud-based medical interoperability platform is provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Online platform for managing and storing health records
|
|
| Locked | Locked | Locked |
Interoperability solutions for healthcare organisations are provided by EMIS Health.
|
|
| Locked | Locked | Locked |
Provider of therapy and care planning solutions using interoperable clinical data
|
Detailed competitors of Q Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Q Bio
Complete news archive for Q Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Q Bio
Q Bio was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Q Bio is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Jeffrey Kaditz is the current CEO of Q Bio. They have also founded this company.
Q Bio is a funded company, having raised a total of $67.1M across 4 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Q Bio is 27.
Q Bio was founded in 2015 and is headquartered in Redwood City, United States. Operations focus on the health technology sector, where clinical data from various diagnostic sources is managed and analyzed. Solutions are developed to derive insights on physiology, with biomarkers examined across genetic, chemical, and anatomical datasets. The platform supports analytics for clinical relevance in stealth mode.
Q Bio offers Gemini Exam and Digital Twin.
Q Bio has 7 investors. Key investors include Khosla Ventures, Andreessen Horowitz, Founders Fund, BEAST, and Sealane Ventures.